These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 38385427)
21. Voriconazole inhibition of tacrolimus metabolism in a kidney transplant recipient with fluconazole-resistant cryptococcal meningitis. Chang HH; Lee NY; Ko WC; Lee HC; Yang YH; Wu CJ; Chang CM Int J Infect Dis; 2010 Apr; 14(4):e348-50. PubMed ID: 19665407 [TBL] [Abstract][Full Text] [Related]
22. Impact of Clotrimazole Fungal Prophylaxis on Tacrolimus Exposure in Kidney Transplant Recipients: A Retrospective Study. El-Sayed A; Vidal J; Khanmoradi K; Knorr JP Transplant Proc; 2021 Jun; 53(5):1583-1588. PubMed ID: 33962777 [TBL] [Abstract][Full Text] [Related]
36. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Momper JD; Ridenour TA; Schonder KS; Shapiro R; Humar A; Venkataramanan R Am J Transplant; 2011 Sep; 11(9):1861-7. PubMed ID: 21714845 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of tacrolimus in adult renal transplant recipients. Naik P; Madhavarapu M; Mayur P; Nayak KS; Sritharan V Drug Metabol Drug Interact; 2012; 27(3):151-5. PubMed ID: 23089531 [TBL] [Abstract][Full Text] [Related]
38. Prophylaxis of chronic kidney disease after liver transplantation--experience from west China. Shao ZY; Yan LN; Wang WT; Li B; Wen TF; Yang JY; Xu MQ; Zhao JC; Wei YG World J Gastroenterol; 2012 Mar; 18(9):991-8. PubMed ID: 22408361 [TBL] [Abstract][Full Text] [Related]
39. Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation. Yaowakulpatana K; Vadcharavivad S; Ingsathit A; Areepium N; Kantachuvesiri S; Phakdeekitcharoen B; Sukasem C; Sra-Ium S; Sumethkul V; Kitiyakara C Eur J Clin Pharmacol; 2016 Mar; 72(3):277-83. PubMed ID: 26635230 [TBL] [Abstract][Full Text] [Related]
40. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients. Lam H; Jeffery J; Sitar DS; Aoki FY Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]